Obsidian Therapeutics
Meghan Langley has a strong background in scientific research and pharmaceutical development. Meghan has worked in various roles at companies such as Obsidian Therapeutics, Celgene, Biogen, Genzyme, Amgen, and Tularik. Meghan holds a Bachelor of Science degree in Wildlife Biology from the University of Massachusetts Amherst and a certificate in Biopharmaceutical Regulatory Affairs from Northeastern University.
This person is not in the org chart